Bacillus polyfermenticus treatment reduced ErbB2, ErbB3, cyclin D1, and E2F-1 transcription factor in HT-29, DLD-1, and Caco-2 colon cancer cells. This evidence concerns the gene CCND1 and malignant colon neoplasm.